Navigation Links
BioLineRx Reports Third Quarter 2013 Financial Results
Date:11/13/2013

liabilities

24,011

15,460

4,371NON-CURRENT LIABILITIESRetirement benefit obligations

143

143

41Warrants

10,725

13,165

3,722Total non-current liabilities

10,868

13,308

3,763COMMITMENTS AND CONTINGENT LIABILITIESTotal liabilities

34,879

28,768

8,134EQUITYOrdinary shares

1,837

2,357

666Share premium

464,629

504,309

142,581Capital reserve

33,802

33,981

9,607Accumulated deficit

(444,339)

(490,413)

(138,652)Total equity

55,929

50,234

14,202Total liabilities and equity90,808

79,002

22,336 BioLineRx Ltd.CONDENSED CONSOLIDATED INTERIM STATEMENT OF COMPREHENSIVE LOSS(UNAUDITED)Convenience translationinto USDThree monthsNine monthsThree months endedSeptember 30,Nine months endedSeptember 30,ended
September 30,ended
September 30,201220132012201320132013NIS in thousandsIn thousandsRESEARCH AND DEVELOPMENT EXPENSES, NET(15,848)

(8,190)

(46,523)

(39,720)

(2,316)

(11,230)SALES AND MARKETING EXPENSES(912)

(731)

(2,626)

(2,565)

(207)

(725)GENERAL AND ADMINISTRATIVE EXPENSES(2,834)

(2,663)

(9,315)

(9,789)

(752)

(2,767)OPERATING LOSS(19,594)

(11,584)

(58,464)

(52,074)

(3,275)

(14,722)NON-OPERATING INCOME (EXPENSES), NET(3,180)

(4,627)

2,351

9,214

(1,308)

2,605FINANCIAL INCOME1,827

501

8,323

2,484

142

702FINANCIAL EXPENSES(1,649)

(1,956)

(4,052)

(5,698)

(553)

(1,611)COMPREHENSIVE LOSS FOR THE PERIOD(22,596)

(17,666)

(51,842)

(46,074)

(4,994)


'/>"/>
SOURCE BioLineRx Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. BioLineRx to Report Third Quarter 2013 Results on November 13, 2013
2. BioLineRx to Hold Analyst and Investor Day in New York on November 21, 2013
3. BioLineRx Receives Regulatory Approval to Commence Phase 1/2 Trial for Novel Treatment of Celiac Disease
4. BioLineRx Announces In-Licensing of BL-9020, for Treatment of Type 1 Diabetes
5. BioLineRx Announces Regulatory Submission for Phase 1/2 Trial for Novel Treatment of Celiac Disease
6. BioLineRx Announces Receipt of a Notice of Allowance from USPTO for Patent on Use of BL-8020, an Oral, Interferon-Free Treatment for Hepatitis C
7. BioLineRx To Present At 15th Annual Rodman & Renshaw Global Investment Conference In New York
8. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
9. BioLineRx to Present at 15th International Celiac Disease Symposium
10. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
11. BioLineRx Appoints B. J. Bormann to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across the ... select Meijer pharmacies in Michigan will ... eligible patients, enabling Meijer pharmacists to administer tests and, in ... by a physician participating in the study. The ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... 1 Allen Medical Systems, a Hill-Rom company, (NYSE: ... Spotlight Series showcasing interviews with top orthopaedic surgeons. Carlos ... Institute, is the featured surgeon and is recognized for ... Intraoperative Arm Positioner for elbow fractures, scopes and clavicle ...
... Therapeutics, Inc. (OTC Bulletin Board: ECTE), a ... as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) ... delivery, announced today that Patrick T. Mooney, M.D., Chairman ... Annual JMP Securities Healthcare Conference on Tuesday, October 6, ...
Cached Medicine Technology:Allen Medical Systems Announces Surgeon Spotlight Series Interview 2Allen Medical Systems Announces Surgeon Spotlight Series Interview 3Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference 2
(Date:7/10/2014)... CLEVELAND The U.S. Department of Health and Human ... Hospitals (UH) Case Medical Center Seidman Cancer Center totaling ... at improving care for patients with complex cancer. ... a unique model developed at UH to enhance care ... or demonstrated need for high health care utilization. ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) ... quality of life. Some patients have disturbed sleep/wake ... asleep, while other patients may be subject to ... extreme, PD patients may exhibit REM-sleep behavior disorder ... re-enactment, even before motor symptoms appear. A review ...
(Date:7/10/2014)... Katerina Alba,s research at the University of Huddersfield could ... most popular emulsion-based food products such as butter, ... starting to gain an international profile for her work. ... food science at the University and now she has ... her supervisor, Dr Vassilis Kontogiorgos, she is investigating the ...
(Date:7/10/2014)... 10, 2014) A research review identifying the clinical ... first step in the process of developing evidence-based guidelines ... new report published by Neurosurgery , ... Surgeons . The journal is published by Lippincott ... Wolters Kluwer Health . , Based on analysis ...
(Date:7/10/2014)... Spring Harbor, NY For decades, health-conscious people around ... rich in antioxidants, figuring this was one of the ... , Yet clinical trials of antioxidant supplements have ... hoping to reduce their cancer risk. Virtually all ... against cancer. In fact, in several trials antioxidant ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:How antioxidants can accelerate cancers, and why they don't protect against them 2
... and amoxicillin when it comes to treating ailments like ... effective. Doctors, who reviewed the treatment given to // ... the newer drugs is more effective than the traditional ... ,Pediatricians at the University of Rochester Medical Center found ...
... treatment by Andrew Lamerton, a vascular surgeon, until he ... lead to the patient being confined to a wheelchair. ... only aggravated Smith’s condition, and he would feel better ... County Hospital supported the doctor, as the National Institute ...
... A new research has revealed that happiness results ... The Psychological Bulletin of the American Psychological Association ... reinforcing positive emotions, which also motivates people to ... ,Dr. Sonja Lyubomirsky of the University ...
... awareness regarding beauty and body solutions, the demand for ... steadily over the recent years. The healthy competition amongst ... has not only resulted in improved outcomes but also ... was previously underdeveloped when compared to the other Indian ...
... during the course of the winter and fall months, from ... to overcome the seasonal affective disorder (SAD), and the people ... ,Those who suffer from SAD overeat, sleep a lot, and ... and develop an aversion to social interactions. The lesser sunlight ...
... anti-inflammatory drug Bextra, meant for those who suffer from arthritis. ... cardiovascular risks, including the possibility of // triggering strokes and ... ,The drug is also known to cause severe skin ... earlier withdrawn the drug which belongs to the cox-2 inhibitors ...
Cached Medicine News:Health News:Penicillin To Pave Way For New Antibiotics 2Health News:Happiness Plays An Important Role In Success 2Health News:New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand 2
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
Medicine Products: